跳至主要内容
临床试验/JPRN-UMIN000043918
JPRN-UMIN000043918已完成未知

A prospective observational study to investigate the safety of SARS-CoV-2 vaccine in patients with lung cancer who are treated or will be treated with anticancer medication (OLCSG2102) - A prospective observational study to investigate the safety of SARS-CoV-2 vaccine in patients with lung cancer who are treated or will be treated with anticancer medication (OLCSG2102)

Iwakuni Clinical Center0 个研究点目标入组 500 人开始时间: 2021年4月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with a history of developing COVID-19 2) Patients with a history of SARS-CoV-2 vaccination 3) Patients who think that it is inappropriate for their doctor to inoculate SARS-CoV-2 vaccine 4) Patients with an estimated prognosis within 2 months

研究者

发起方
Iwakuni Clinical Center

相似试验

A prospective observational study to investigate the... | 临床试验